248 related articles for article (PubMed ID: 11839575)
1. Versican is differentially expressed in human melanoma and may play a role in tumor development.
Touab M; Villena J; Barranco C; Arumí-Uría M; Bassols A
Am J Pathol; 2002 Feb; 160(2):549-57. PubMed ID: 11839575
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of versican isoforms is a component of the human melanoma cell differentiation process.
Domenzain C; Docampo MJ; Serra M; Miquel L; Bassols A
Biochim Biophys Acta; 2003 Sep; 1642(1-2):107-14. PubMed ID: 12972299
[TBL] [Abstract][Full Text] [Related]
3. Expression of the proteoglycans versican and mel-CSPG in dysplastic nevi.
Touab M; Arumi-Uría M; Barranco C; Bassols A
Am J Clin Pathol; 2003 Apr; 119(4):587-93. PubMed ID: 12710131
[TBL] [Abstract][Full Text] [Related]
4. Role of versican V0/V1 and CD44 in the regulation of human melanoma cell behavior.
Hernández D; Miquel-Serra L; Docampo MJ; Marco-Ramell A; Bassols A
Int J Mol Med; 2011 Feb; 27(2):269-75. PubMed ID: 21136024
[TBL] [Abstract][Full Text] [Related]
5. V3 versican isoform expression alters the phenotype of melanoma cells and their tumorigenic potential.
Serra M; Miquel L; Domenzain C; Docampo MJ; Fabra A; Wight TN; Bassols A
Int J Cancer; 2005 May; 114(6):879-86. PubMed ID: 15645431
[TBL] [Abstract][Full Text] [Related]
6. Expression of a chondroitin sulfate proteoglycan, versican (PG-M), during development of rat cornea.
Koga T; Inatani M; Hirata A; Inomata Y; Zako M; Kimata K; Oohira A; Gotoh T; Mori M; Tanihara H
Curr Eye Res; 2005 Jun; 30(6):455-63. PubMed ID: 16020278
[TBL] [Abstract][Full Text] [Related]
7. Versican/PG-M G3 domain promotes tumor growth and angiogenesis.
Zheng PS; Wen J; Ang LC; Sheng W; Viloria-Petit A; Wang Y; Wu Y; Kerbel RS; Yang BB
FASEB J; 2004 Apr; 18(6):754-6. PubMed ID: 14766798
[TBL] [Abstract][Full Text] [Related]
8. V3 versican isoform expression has a dual role in human melanoma tumor growth and metastasis.
Miquel-Serra L; Serra M; Hernández D; Domenzain C; Docampo MJ; Rabanal RM; de Torres I; Wight TN; Fabra A; Bassols A
Lab Invest; 2006 Sep; 86(9):889-901. PubMed ID: 16847433
[TBL] [Abstract][Full Text] [Related]
9. Effect of transforming growth factor-beta1, insulin-like growth factor-I, and hepatocyte growth factor on proteoglycan production and regulation in canine melanoma cell lines.
Serra M; Pastor J; Domenzain C; Bassols A
Am J Vet Res; 2002 Aug; 63(8):1151-8. PubMed ID: 12171170
[TBL] [Abstract][Full Text] [Related]
10. Versican overexpression in cutaneous malignant melanoma.
Gambichler T; Kreuter A; Grothe S; Altmeyer P; Brockmeyer NH; Rotterdam S
Eur J Med Res; 2008 Nov; 13(11):500-4. PubMed ID: 19073385
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta as a key molecule triggering the expression of versican isoforms v0 and v1, hyaluronan synthase-2 and synthesis of hyaluronan in malignant osteosarcoma cells.
Nikitovic D; Zafiropoulos A; Katonis P; Tsatsakis A; Theocharis AD; Karamanos NK; Tzanakakis GN
IUBMB Life; 2006 Jan; 58(1):47-53. PubMed ID: 16540432
[TBL] [Abstract][Full Text] [Related]
12. Versican G3 domain enhances cellular adhesion and proliferation of bovine intervertebral disc cells cultured in vitro.
Yang BL; Yang BB; Erwin M; Ang LC; Finkelstein J; Yee AJ
Life Sci; 2003 Nov; 73(26):3399-413. PubMed ID: 14572881
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of CD44 in canine melanocytic tumours.
Serra M; Rabanal RM; Miquel L; Domenzain C; Bassols A
J Comp Pathol; 2004; 130(2-3):171-80. PubMed ID: 15003475
[TBL] [Abstract][Full Text] [Related]
14. Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma.
Massi D; Naldini A; Ardinghi C; Carraro F; Franchi A; Paglierani M; Tarantini F; Ketabchi S; Cirino G; Hollenberg MD; Geppetti P; Santucci M
Hum Pathol; 2005 Jun; 36(6):676-85. PubMed ID: 16021575
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the C-terminal PG-M/versican domain impairs growth of tumor cells by intervening in the interaction between epidermal growth factor receptor and beta1-integrin.
Wu Y; Chen L; Cao L; Sheng W; Yang BB
J Cell Sci; 2004 May; 117(Pt 11):2227-37. PubMed ID: 15126624
[TBL] [Abstract][Full Text] [Related]
16. The globular domains of PG-M/versican modulate the proliferation-apoptosis equilibrium and invasive capabilities of tumor cells.
Cattaruzza S; Schiappacassi M; Kimata K; Colombatti A; Perris R
FASEB J; 2004 Apr; 18(6):779-81. PubMed ID: 14977887
[TBL] [Abstract][Full Text] [Related]
17. Versican: signaling to transcriptional control pathways.
Rahmani M; Wong BW; Ang L; Cheung CC; Carthy JM; Walinski H; McManus BM
Can J Physiol Pharmacol; 2006 Jan; 84(1):77-92. PubMed ID: 16845893
[TBL] [Abstract][Full Text] [Related]
18. The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis.
Sheng W; Wang G; Wang Y; Liang J; Wen J; Zheng PS; Wu Y; Lee V; Slingerland J; Dumont D; Yang BB
Mol Biol Cell; 2005 Mar; 16(3):1330-40. PubMed ID: 15635104
[TBL] [Abstract][Full Text] [Related]
19. Differential versican isoforms and aggrecan expression in the chicken embryo aorta.
Arciniegas E; Neves CY; Candelle D; Parada D
Anat Rec A Discov Mol Cell Evol Biol; 2004 Jul; 279(1):592-600. PubMed ID: 15224401
[TBL] [Abstract][Full Text] [Related]
20. Versican enhances locomotion of astrocytoma cells and reduces cell adhesion through its G1 domain.
Ang LC; Zhang Y; Cao L; Yang BL; Young B; Kiani C; Lee V; Allan K; Yang BB
J Neuropathol Exp Neurol; 1999 Jun; 58(6):597-605. PubMed ID: 10374750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
